Filing Details
- Accession Number:
- 0001213900-17-012293
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-17 16:32:43
- Reporting Period:
- 2017-11-15
- Accepted Time:
- 2017-11-17 16:32:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1498382 | Delmar Pharmaceuticals Inc. | DMPI | Pharmaceutical Preparations (2834) | 990360497 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1569585 | K John Bell | Suite 720-999 West Broadway Vancouver A1 V5Z 1K5 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-15 | 1,871 | $0.81 | 76,890 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2017-11-16 | 18,129 | $0.81 | 95,019 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $0.7997 to $0.84. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $0.8086 to $0.81. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares are held by Onbelay Capital Inc.